Name: Catalyst Pharmaceuticals, Inc. (CPRX) Balance Sheet
Creator: FinSpry

Catalyst Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Catalyst Pharmaceuticals, Inc. (CPRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	517.55	137.64	298.40	171.45	130.24	94.52	53.48
Short-Term Investments	0.00	0.00	0.00	19.82	10.04	0.00	0.00
Cash & Short-Term Investments	517.55	137.64	298.40	191.27	140.28	94.52	53.48
Accounts Receivable	65.48	53.65	10.44	6.72	6.42	10.54	0.00
Inventory	19.54	15.64	6.81	7.87	4.65	1.96	0.06
Other Current Assets	1.03	12.05	0.35	3.92	7.45	0.00	0.30
Total Current Assets	623.61	219.33	320.81	210.11	159.24	111.36	55.19
Non-Current Assets
Property, Plant & Equipment (Net)	3.58	3.70	3.62	3.98	0.13	0.79	0.25
Long-Term Investments	21.56	16.49	0.00	0.00	0.00	0.00	0.00
Intangible Assets	156.67	194.05	32.47	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.01	0.01	0.00	0.00
Total Non-Current Assets	227.80	250.79	54.82	27.68	33.11	0.80	5.26
Total Assets	851.41	470.11	375.63	237.79	192.35	112.38	60.45
Current Liabilities
Accounts Payable	16.59	14.80	3.98	2.77	4.26	24.10	7.47
Short-Term Debt	0.40	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	88.04	40.29	26.08	21.95	17.40	0.00	0.00
Other Current Liabilities	0.42	19.88	0.24	1.96	1.07	0.00	0.07
Total Current Liabilities	120.68	76.06	57.59	27.06	22.76	24.10	9.51
Non-Current Liabilities
Long-Term Debt	2.79	3.19	3.56	3.89	0.00	0.65	0.00
Other Non-Current Liabilities	0.32	2.98	14.06	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	3.10	6.17	17.62	3.89	0.06	0.65	0.15
Total Liabilities	123.78	82.23	75.21	30.96	22.76	24.75	9.67
Stockholders' Equity
Common Stock	0.12	0.11	0.11	0.10	0.10	0.00	0.00
Retained Earnings	285.16	121.27	49.86	-26.31	-53.71	-128.69	-160.56
Accumulated Other Comprehensive Income	0.06	0.01	0.02	-0.15	0.03	0.01	-0.02
Additional Paid-in Capital	442.29	266.49	250.43	233.19	223.17	216.21	211.27
Shares Outstanding	120.88	107.12	105.26	102.99	0.00	0.00	0.00
Total Stockholders' Equity	727.63	387.88	300.42	206.83	169.60	87.63	50.78
Total Liabilities & Equity	851.41	470.11	375.63	237.79	192.35	112.38	60.45